Partnering Strategy

Starpharma adopts a partnering strategy in which, usually after proof of concept by Starpharma, one or more sector-leading partners are identified with the expertise and resources to advance products to market.


The partner-led approach helps to ensure that Starpharma can remain focused on its core “platform” competencies whilst maximizing the opportunities for commercialization of the technology.


Starpharma’s commercialising partners include:

  • Ansell
  • Okamoto
  • Lilly
  • GSK’s Stiefel Laboratories Inc
  • AstraZeneca
  • Siemens Healthcare
  • EMD Merck
  • Nufarm
  • Sigma-Aldrich
  • Makhteshim Agan


Contact Us if you are interested in establishing a partnership with Starpharma.





© Starpharma Holdings Limited 2017